ArticleJournal of clinical medicine2024

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

Luana Fianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.